Contact: +91-9711224068
  • Printed Journal
  • Indexed Journal
  • Refereed Journal
  • Peer Reviewed Journal
International Journal of Pharmaceutical and Clinical Research

Vol. 1, Issue 1, Part A (2019)

The importance of medical patient relationship in therapeutic adherence in people living with type 2 Diabetes

Author(s):

Viridiana Vázquez Morales, Josefina Reynoso Vázquez, Maricarmen Rivera Gómez, Lorenzo Octavio Aguirre Rembao, Jesús Carlos Ruvalcaba Ledezma

Abstract:
The behavior and coping modes of people living with type 2 Diabetes can play an important role in their course and the fact that a patient complies with medical prescriptions plays a primary role in the control of the same. Adherence to treatment depends on the patient's behavior, but is also closely related to the physician's behavior. The behavior of the patient is influenced in the way of approaching the doctor towards the disease that he suffers, being at present the doctor-patient relationship, one of the important factors to consider in order to design strategies that strengthen the therapeutic adherence in these patients and decrease the economic waste that currently exists in health due to failure in attachment. Objective. Carry out an analysis about the patient medical relationship as an important element that influences adherence to treatment in people living with type 2 Diabetes. Conclusion. The doctor as first contact has a great responsibility to be the one who educates the patient as to his illness. This is currently perpetuated by the existence of an excessive workload that in the public health services, which is why it is necessary to establish new models of care.

Pages: 21-24  |  1694 Views  701 Downloads


International Journal of Pharmaceutical and Clinical Research
How to cite this article:
Viridiana Vázquez Morales, Josefina Reynoso Vázquez, Maricarmen Rivera Gómez, Lorenzo Octavio Aguirre Rembao, Jesús Carlos Ruvalcaba Ledezma. The importance of medical patient relationship in therapeutic adherence in people living with type 2 Diabetes. Int. J. Pharm. Clin. Res. 2019;1(1):21-24. DOI: 10.33545/26647591.2019.v1.i1a.5
Call for book chapter